HomeCompareABT vs SHW

ABT vs SHW: Dividend Comparison 2026

ABT yields 2.36% · SHW yields 1.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABT wins by $224.3K in total portfolio value
10 years
ABT
ABT
● Live price
2.36%
Share price
$101.89
Annual div
$2.40
5Y div CAGR
63.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$533.6K
Annual income
$328,772.04
Full ABT calculator →
SHW
SHW
● Live price
1.00%
Share price
$315.90
Annual div
$3.17
5Y div CAGR
76.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$309.3K
Annual income
$185,821.41
Full SHW calculator →

Portfolio growth — ABT vs SHW

📍 ABT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABTSHW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABT + SHW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABT pays
SHW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABT
Annual income on $10K today (after 15% tax)
$200.23/yr
After 10yr DRIP, annual income (after tax)
$279,456.23/yr
SHW
Annual income on $10K today (after 15% tax)
$85.30/yr
After 10yr DRIP, annual income (after tax)
$157,948.20/yr
At 15% tax rate, ABT beats the other by $121,508.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABT + SHW for your $10,000?

ABT: 50%SHW: 50%
100% SHW50/50100% ABT
Portfolio after 10yr
$421.4K
Annual income
$257,296.72/yr
Blended yield
61.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABT right now

ABT
Analyst Ratings
30
Buy
10
Hold
Consensus: Buy
Price Target
$137.67
+35.1% upside vs current
Range: $120.00 — $158.00
Altman Z
4.9
Piotroski
6/9
SHW
Analyst Ratings
24
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$396.83
+25.6% upside vs current
Range: $371.00 — $420.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABT buys
0
SHW buys
14
PoliticianChamberTickerTypeAmountDate
Jared Moskowitz🏢 House$SHW▼ Sell$15,001 - $50,0002025-10-10
Jared Moskowitz🏢 House$SHW▼ Sell$1,001 - $15,0002025-10-10
Jared Moskowitz🏢 House$SHW▼ Sell$1,001 - $15,0002025-10-10
Ro Khanna🏢 House$SHW▼ Sell$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$SHW▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$SHW▲ Buy$1,001 - $15,0002025-08-26
Shelley Moore Capito🏛 Senate$SHW▲ Buy$1,001 - $15,0002025-08-01
Shelley Moore Capito🏛 Senate$SHW▲ Buy$1,001 - $15,0002025-08-01
Ro Khanna🏢 House$SHW▲ Buy$1,001 - $15,0002025-07-25
Valerie Hoyle🏢 House$SHW▼ Sell$1,001 - $15,0002025-07-14
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABTSHW
Forward yield2.36%1.00%
Annual dividend / share$2.40$3.17
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR63.2%76.6%
Portfolio after 10y$533.6K$309.3K
Annual income after 10y$328,772.04$185,821.41
Total dividends collected$492.4K$277.6K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyBuy
Analyst price target$137.67$396.83

Year-by-year: ABT vs SHW ($10,000, DRIP)

YearABT PortfolioABT Income/yrSHW PortfolioSHW Income/yrGap
1← crossover$11,084$384.43$10,877$177.21+$207.00ABT
2$12,510$649.94$11,957$318.14+$553.00ABT
3$14,505$1,118.82$13,371$577.20+$1.1KABT
4$17,499$1,978.53$15,372$1,065.33+$2.1KABT
5$22,364$3,640.59$18,470$2,021.46+$3.9KABT
6$31,026$7,096.70$23,771$4,008.63+$7.3KABT
7$48,215$15,016.56$33,950$8,515.19+$14.3KABT
8$87,182$35,592.30$56,399$20,072.16+$30.8KABT
9$191,446$98,161.15$115,381$55,033.62+$76.1KABT
10$533,619$328,772.04$309,279$185,821.41+$224.3KABT

ABT vs SHW: Complete Analysis 2026

ABTHealthcare

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Full ABT Calculator →

SHWMaterials

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group. The Americas Group segment offers architectural paints and coatings, and protective and marine products, as well as OEM product finishes and related products for architectural and industrial paint contractors, and do-it-yourself homeowners. The Consumer Brands Group segment supplies a portfolio of branded and private-label architectural paints, stains, varnishes, industrial products, wood finishes products, wood preservatives, applicators, corrosion inhibitors, aerosols, caulks, and adhesives to retailers and distributors. The Performance Coatings Group segment develops and sells industrial coatings for wood finishing and general industrial applications, automotive refinish products, protective and marine coatings, coil coatings, packaging coatings, and performance-based resins and colorants. It serves retailers, dealers, jobbers, licensees, and other third-party distributors through its branches and direct sales staff, as well as through outside sales representatives. The company has operations primarily in the North and South America, the Caribbean, Europe, Asia, and Australia. As of February 17, 2022, it operated approximately 5,000 company-operated stores and facilities. The Sherwin-Williams Company was founded in 1866 and is headquartered in Cleveland, Ohio.

Full SHW Calculator →
📬

Get this ABT vs SHW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABT vs SCHDABT vs JEPIABT vs OABT vs KOABT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.